Flora Growth shareholders reject SAR grants to top executives; approve reverse split, plan amendment and SAR repricing

ZeroStack Corp.

Proposal 4 (grant of Stock Appreciation Rights to CEO, CFO, Executive Chairman) rejected with 7.5M against vs 1.3M for.
Amendment to 2022 Incentive Plan approved, increasing share reserve from 2.5M to 4.5M shares.
Share consolidation (reverse split) authorized at ratio 10:1 to 100:1, at Board's discretion within one year.
Repricing of outstanding SARs to $0.58 base price approved; vesting tied to share price increases of 25% per tranche.
All five directors elected; auditor reappointment and all other proposals passed except Proposal 4.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.